Pharma and HealthcareCase Study: Does Branding Impact Sales?How OSG helped a global pharmaceutical company evaluate and prioritize potential scientific statements intended to launch an unbranded campaign to educate physicians before the launch of Drug X.A global pharmaceutical company and its agency of record were planning to launch an unbranded campaign to shape the opioid-induced nausea and vomiting (OINV) treatment market for the later launch of Drug X and thus wanted to test potential scientific statements that would boost this campaign. Using OSG’s AI-driven big data analytics platform, we conducted research in the United States to prioritize messages designed to launch a campaign that educates physicians about OINV and drives them to seek more information.Download Case Study - Unbranded Message Testing for a Global Pharmaceutical CompanyCheck out more of our case studies:Case Study: Differentiation for BiosimilarsHow OSG’s technology helped a pharma company stand out in their first foray into an already crowded category of biosimilar products, through stakeholder understanding and position and reputation management.Read moreCase Study: Empowering Electrical ContractorsHow OSG helped a global specialist in energy management and automation build a measurement infrastructure to better engage with customers to impact acquisition and purchases.Read more
